Latest: FDA Approves New Biosimilar for Oncology Treatment

Medical cannabis has a high discontinuation rate for treatment of musculoskeletal pain

0 Mins

1. Medical cannabis has a high discontinuation rate among patients with chronic musculoskeletal pain, particularly in the first few months, particularly in older patients 2. Pain location and baseline health status are not reliable indicators of whether a patient will continue medical cannabis use. Evidence Rating Level: 3 (Average) In this retrospective study, 78 patients […]

The post Medical cannabis has a high discontinuation rate for treatment of musculoskeletal pain first appeared on 2 Minute Medicine.
Tags:
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago